Isabel Virella-Lowell
Affiliations: | Medical University of South Carolina, Charleston, SC, United States |
Area:
Microbiology Biology, Molecular BiologyGoogle:
"Isabel Virella-Lowell"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sommerwerck U, Virella-Lowell I, Angyalosi G, et al. (2016) Long-Term Safety of Tobramycin Inhalation Powder in Patients with Cystic Fibrosis: Phase IV (ETOILES) Study. Current Medical Research and Opinion. 1-25 |
| Buff SM, Yu H, McCall JN, et al. (2010) IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia. Gene Therapy. 17: 567-76 |
| Yu H, Zeidan YH, Wu BX, et al. (2009) Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis. American Journal of Respiratory Cell and Molecular Biology. 41: 367-75 |
| Yu H, Buff SM, Baatz JE, et al. (2008) Oral instillation with surfactant phospholipid: a reliable alternative to intratracheal injection in mouse studies. Laboratory Animals. 42: 294-304 |
| Virella-Lowell I, Zusman B, Foust K, et al. (2005) Enhancing rAAV vector expression in the lung. The Journal of Gene Medicine. 7: 842-50 |
| Virella-Lowell I, Herlihy JD, Liu B, et al. (2004) Effects of CFTR, interleukin-10, and Pseudomonas aeruginosa on gene expression profiles in a CF bronchial epithelial cell Line. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 562-73 |
| Flotte TR, Virella-Lowell I, Chesnut KA. (2002) Adeno-associated viral vectors for CF gene therapy Methods in Molecular Medicine. 70: 599-608 |
| Virella-Lowell I, Poirier A, Chesnut KA, et al. (2000) Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients. Gene Therapy. 7: 1783-9 |